Alap-ap, Baby Girl .
HRN: 25-60-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/27/2024
09/02/2024
IVT
45mg
Q24
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes